Tencent invests in Minwei Biotech, an innovative drug developer under Lepu Medical
According to the Qichacha APP, recently, Shanghai Minwei Biotechnology Co., Ltd. underwent a business change, adding Guangxi Tencent Venture Capital Co., Ltd. as a shareholder, while the registered capital increased to approximately 16.16 million yuan. Qichacha information shows that the company was established in 2021, with Zhang Bingfeng as the legal representative. Its business scope includes technology development in the fields of biotechnology and medical technology, and its major shareholder is Lepu Medical. Public information indicates that the company focuses on cutting-edge "multi-core large molecule biopharmaceutical" innovation and platform development, aiming to create globally competitive innovative drugs
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments